Ghent University Academic Bibliography

Granulocyte colony-stimulating factor : missing link for stratification of type 2-high and type 2-low chronic rhinosinusitis patients

Sharon Van Nevel (UGent) , Jozefien Declercq (UGent) , Gabriële Holtappels (UGent) , Bart Lambrecht (UGent) and Claus Bachert (UGent)

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY.

Add to list

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

Claus Bachert (UGent) , Anju T. Peters, Enrico Heffler, Joseph K. Han, Heidi Olze, Oliver Pfaar, Chien‐Chia Chuang, Raj Rout, Richa Attre, Ledia Goga, et al.

(2022) CLINICAL AND EXPERIMENTAL ALLERGY. 52(2). p.244-249

Add to list

Miscellaneous
open access

Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps : association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials

Claus Bachert (UGent) , Jonathan Corren, Stella E. Lee, Haixin Zhang, Sivan Harel, Danen Cunoosamy, Asif H. Khan, Juby A. Jacob‐Nara, Shahid Siddiqui, Scott Nash, et al.

(2022) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY.

Add to list

Journal Article
A1
open access

The protease SplB of staphylococcus aureus targets host complement components and inhibits complement-mediated bacterial opsonophagocytosis

Prasad Dasari, Maria Nordengrün, Cláudia Vilhena, Leif Steil, Goran Abdurrahman, Kristin Surmann, Vishnu Dhople, Julia Lahrberg, Claus Bachert (UGent) , Christine Skerka, et al.

(2022) JOURNAL OF BACTERIOLOGY. 204(1).

Add to list

Journal Article
A1
open access

Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis

Joseph K. Han, Claus Bachert (UGent) , Stella E. Lee, Claire Hopkins, Enrico Heffler, Peter Hellings (UGent) , Anju T. Peters, Siddhesh Kamat, Diane Whalley, Shanshan Qin, et al.

(2022) LARYNGOSCOPE. 132(2). p.265-271

Add to list

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial

Claus Bachert (UGent) , Joseph K. Han, Martin Y. Desrosiers, Philippe Gevaert (UGent) , Enrico Heffler, Claire Hopkins, Jody R. Tversky, Peter Barker, David Cohen, Claire Emson, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(4). p.1309-1317.e12

Add to list

Journal Article
A1
open access

Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers

Debbie J. Maurer, Chengyao Liu, Paraskevi Xepapadaki, Barbara Stanic, Claus Bachert (UGent) , Susetta Finotto, Ya‐Dong Gao, Anna Graser, Tuomas Jartti, Walter Kistler, et al.

(2022) ALLERGY. 77(4). p.1216-1230

Add to list

Journal Article
A1
open access

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert (UGent) , Leda P. Mannent, G. Walter Canonica, Joseph K. Han, Jorge F. Maspero, Cesar Picado, Nadia Daizadeh, Benjamin Ortiz, et al.

(2022) ALLERGY. 77(4). p.1231-1244

Add to list

Journal Article
A1
open access

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

Shigeharu Fujieda, Shoji Matsune, Sachio Takeno, Nobuo Ohta, Mikiya Asako, Claus Bachert (UGent) , Tomoyuki Inoue, Yoshinori Takahashi, Hiroyuki Fujita, Yamo Deniz, et al.

(2022) ALLERGY. 77(1). p.186-196

Add to list

Journal Article
A1
open access

Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Chien‐Chia Chuang, Isabelle Guillemin, Claus Bachert (UGent) , Stella E. Lee, Peter Hellings (UGent) , Wytske J. Fokkens, Nicolas Duverger, Chunpeng Fan, Nadia Daizadeh, Nikhil Amin, et al.

(2022) LARYNGOSCOPE. 132(2). p.259-264

Academic Bibliography

Granulocyte colony-stimulating factor : missing link for stratification of type 2-high and type 2-low chronic rhinosinusitis patients

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps : association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials

The protease SplB of staphylococcus aureus targets host complement components and inhibits complement-mediated bacterial opsonophagocytosis

Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial

Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Contents

Support

Contact